Evotec (NASDAQ:EVO) reported quarterly losses of $(0.15) per share which missed the analyst consensu

Evotec (NASDAQ:EVO) affirms FY2026 sales outlook from $667.470 million-$714.310 million to $667.470

Evotec AG (NASDAQ: EVO - Get Free Report) has been given a consensus recommendation of "Hold" by the

Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Di

Collaboration combines Odyssey's disease biology expertise with Evotec's AI-enabled discover

Collaboration combines Odyssey's disease biology expertise with Evotec's AI-enabled discovery platfo

LOS ANGELES--(BUSINESS WIRE)---- $NAGE #Biotech--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global

PALO ALTO, Calif.--(BUSINESS WIRE)--Navan (NASDAQ: NAVN), the global AI-powered business travel and

US stock futures mostly higher, Nasdaq up by 100 points. Phoenix Education falls after cutting sales

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Evotec (NASDAQ:EVO) with a Buy a

Evotec SE (EVO) Q2 2026 Earnings Call Transcript

Evotec NASDAQ: EVO reported preliminary unaudited results for the second quarter and first half of 2

Gainers NextCure (NASDAQ:NXTC) shares rose 305.5% to $8.84 during Tuesday's pre-market session.

U.S. stock futures mixed, Nasdaq 100 up 100 pts. Telefonaktiebolaget LM Ericsson falls 9.2% in pre-m

Vision Marine Technologies Inc (NASDAQ: VMAR) gained 60.3% to $2.26 in pre-market trading after repo

Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Yea

Evotec SE (NASDAQ:EVO) (Frankfurt Prime Standard: EVT) today announced preliminary unaudited financi

Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014  HAMBU

Evommune, Inc.'s recent miss with EVO756's CSU indications is a major setback. I agree that this cre

Just - Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for Biologics P

Expands Just – Evotec Biologics partner-enablement and technology licensing model for proprietary co

PALO ALTO, Calif. & NEW YORK--(BUSINESS WIRE)--Evommune, Inc. (NYSE: EVMN) (the “Company” or “Evommu

11.06.2026 / 15:30 CET/CESTThe issuer is solely responsible for the content of this announcement. Al

HAMBURG, DE / ACCESS Newswire / June 2, 2026 / Evotec SE (NASDAQ:EVO)(Frankfurt Prime Standard:EVT)

https://www.cdc.gov/ebola/situation-summary/index.html

Dow futures down 100 points. QuickLogic (QUIK) falls after reporting worse-than-expected Q1 results.

Nextpower Inc (NXT) shares rose in pre-market trading after reporting strong Q4 results, raising sa

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CAN

Evotec (NASDAQ:EVO) raises FY2026 sales outlook from $814.906 million-$908.038 million to $819.700 m

Evotec (NASDAQ:EVO) reported quarterly losses of $(0.40) per share which missed the analyst consensu

Joint Evotec-Almirall team advances small molecule program to preclinical development significantly

Joint Evotec-Almirall team advances small molecule program to preclinical development significantly

Grants support discovery and development of novel drug candidates and evaluation and prioritization

Grants support discovery and development of novel drug candidates and evaluation and prioritization

Nomination of Dr. Wolfgang Hofmann as independent Supervisory Board member to further strengthen ove

HAMBURG, DE / ACCESS Newswire / April 29, 2026 / Evotec SE (NASDAQ:EVO; Frankfurt Prime Standard: EV

U.S. stock futures mixed, Dow down 100 points. Boyd Gaming Corp shares drop 6.1% after worse-than-ex

Evotec (NASDAQ:EVO) reported quarterly earnings of $0.05 per share which beat the analyst consensus

Gilead shares dip after $3.15 billion Tubulis deal adds ADC asset, as multiple acquisitions reshape

The program leverages Just - Evotec Biologics' advanced biomanufacturing platform to deliver hig

Dosing of first patient initiates Phase 1 clinical evaluation of BMS-986506 for the treatment of adv

Evotec launches transformation plan, targeting 75 million euros in savings by 2027 and revenue above

US stocks mixed, Dow down 0.1%, NASDAQ up 0.13%, S&P 500 down 0.08%. Materials sector up, utilit

US stock futures lower, FreightCar America (RAIL) plunges after weak earnings. Other stocks moving l

ZVRA up in pre-market trading on better-than-expected Q4 results. Gainers include BRTX, COOT, BIYA,